(Q37708526)

22 August 2017

1 reference

title

PET-CT for response assessment and treatment adaptation in head and neck cancer (English)

1 reference

22 August 2017

4

Wim J G Oyen

1 reference

22 August 2017

1

Johan Bussink

1 reference

22 August 2017

Carla M L van Herpen

2

1 reference

PubMed ID

20226735

22 August 2017

Johannes H A M Kaanders

series ordinal

3

1 reference

22 August 2017

10 March 2010

1 reference

Lancet Oncology Commission

22 August 2017

1 reference

22 August 2017

11

1 reference

22 August 2017

7

1 reference

22 August 2017

661-669

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970353-5

22 August 2017

1 reference

7 January 2021

Dynamics of hypoxia, proliferation and apoptosis after irradiation in a murine tumor model

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970353-5

7 January 2021

The hazard of accelerated tumor clonogen repopulation during radiotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970353-5

7 January 2021

Hyperfractionated or accelerated radiotherapy in head and neck cancer: a meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970353-5

7 January 2021

Prognostic value of tumor oxygenation in 397 head and neck tumors after primary radiation therapy. An international multi-center study

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970353-5

7 January 2021

Hypoxic radiosensitization: adored and ignored

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970353-5

7 January 2021

A randomized double-blind phase III study of nimorazole as a hypoxic radiosensitizer of primary radiotherapy in supraglottic larynx and pharynx carcinoma. Results of the Danish Head and Neck Cancer Study (DAHANCA) Protocol 5-85.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970353-5

7 January 2021

ARCON: a novel biology-based approach in radiotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970353-5

7 January 2021

Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): an update on 93 randomised trials and 17,346 patients

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970353-5

7 January 2021

Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970353-5

7 January 2021

Hypoxia and glucose metabolism in malignant tumors: evaluation by [18F]fluoromisonidazole and [18F]fluorodeoxyglucose positron emission tomography imaging

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970353-5

7 January 2021

Nuclear medicine imaging to predict response to radiotherapy: a review

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970353-5

7 January 2021

Prognostic relevance of response evaluation using [18F]-2-fluoro-2-deoxy-D-glucose positron emission tomography in patients with locally advanced non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970353-5

7 January 2021

Cellular uptake of PET tracers of glucose metabolism and hypoxia and their linkage.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970353-5

7 January 2021

Assessment of regional tumor hypoxia using 18F-fluoromisonidazole and 64Cu(II)-diacetyl-bis(N4-methylthiosemicarbazone) positron emission tomography: Comparative study featuring microPET imaging, Po2 probe measurement, autoradiography, and fluoresce

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970353-5

7 January 2021

Prognostic significance of [18F]-misonidazole positron emission tomography-detected tumor hypoxia in patients with advanced head and neck cancer randomly assigned to chemoradiation with or without tirapazamine: a substudy of Trans-Tasman Radiation O

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970353-5

7 January 2021

Hypoxia imaging with FAZA-PET and theoretical considerations with regard to dose painting for individualization of radiotherapy in patients with head and neck cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970353-5

7 January 2021

Hypoxic cell turnover in different solid tumor lines

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970353-5

7 January 2021

A kinetic model for dynamic [18F]-Fmiso PET data to analyse tumour hypoxia.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970353-5

7 January 2021

Reproducibility of intratumor distribution of (18)F-fluoromisonidazole in head and neck cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970353-5

7 January 2021

The influence of changes in tumor hypoxia on dose-painting treatment plans based on 18F-FMISO positron emission tomography.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970353-5

7 January 2021

Reproducibility of quantitative 18F-3'-deoxy-3'-fluorothymidine measurements using positron emission tomography

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970353-5

7 January 2021

Correlation of 18F-FLT and 18F-FDG uptake on PET with Ki-67 immunohistochemistry in non-small cell lung cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970353-5

7 January 2021

[18F]FLT PET for diagnosis and staging of thoracic tumours

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970353-5

7 January 2021

18F-FLT PET does not discriminate between reactive and metastatic lymph nodes in primary head and neck cancer patients.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970353-5

7 January 2021

In vivo detection of apoptosis

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970353-5

7 January 2021

Non-invasive PET imaging of EGFR degradation induced by a heat shock protein 90 inhibitor

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970353-5

7 January 2021

Disparity between in vivo EGFR expression and 89Zr-labeled cetuximab uptake assessed with PET.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970353-5

7 January 2021

PET-based biodistribution and radiation dosimetry of epidermal growth factor receptor-selective tracer 11C-PD153035 in humans

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970353-5

7 January 2021

SPECT and PET imaging of EGF receptors with site-specifically labeled EGF and dimeric EGF.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970353-5

7 January 2021

Correlation of [18F]FMISO autoradiography and pimonidazole [corrected] immunohistochemistry in human head and neck carcinoma xenografts

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970353-5

7 January 2021

Tumor hypoxia at the micro-regional level: clinical relevance and predictive value of exogenous and endogenous hypoxic cell markers

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970353-5

7 January 2021

Recommendations on the use of 18F-FDG PET in oncology

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970353-5

7 January 2021

Comparison of whole-body PET/CT, dedicated high-resolution head and neck PET/CT, and contrast-enhanced CT in preoperative staging of clinically M0 squamous cell carcinoma of the head and neck

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970353-5

7 January 2021

18F-FDG uptake in reactive neck lymph nodes of oral cancer: relationship to lymphoid follicles

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970353-5

7 January 2021

18F-fluorodeoxyglucose positron emission tomography to evaluate cervical node metastases in patients with head and neck squamous cell carcinoma: a meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970353-5

7 January 2021

Tumor volume in pharyngolaryngeal squamous cell carcinoma: comparison at CT, MR imaging, and FDG PET and validation with surgical specimen

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970353-5

7 January 2021

Comparison of five segmentation tools for 18F-fluoro-deoxy-glucose-positron emission tomography-based target volume definition in head and neck cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970353-5

7 January 2021

Is PET-based treatment planning the new standard in modern radiotherapy? The head and neck paradigm

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970353-5

7 January 2021

Theragnostic imaging for radiation oncology: dose-painting by numbers

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970353-5

7 January 2021

Positron emission tomography-guided, focal-dose escalation using intensity-modulated radiotherapy for head and neck cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970353-5

7 January 2021

Adaptive biological image-guided IMRT with anatomic and functional imaging in pharyngo-laryngeal tumors: impact on target volume delineation and dose distribution using helical tomotherapy.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970353-5

7 January 2021

Dose painting in radiotherapy for head and neck squamous cell carcinoma: value of repeated functional imaging with (18)F-FDG PET, (18)F-fluoromisonidazole PET, diffusion-weighted MRI, and dynamic contrast-enhanced MRI.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970353-5

7 January 2021

Prospective trial incorporating pre-/mid-treatment [18F]-misonidazole positron emission tomography for head-and-neck cancer patients undergoing concurrent chemoradiotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970353-5

7 January 2021

The limitation of PET imaging for biological adaptive-IMRT assessed in animal models

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970353-5

7 January 2021

Kinetic analysis of 3'-deoxy-3'-(18)F-fluorothymidine ((18)F-FLT) in head and neck cancer patients before and early after initiation of chemoradiation therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970353-5

7 January 2021

Microenvironmental transformations by VEGF- and EGF-receptor inhibition and potential implications for responsiveness to radiotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970353-5

7 January 2021

Activation of the PI3-K/AKT pathway and implications for radioresistance mechanisms in head and neck cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970353-5

7 January 2021

Modulation of intratumoral hypoxia by the epidermal growth factor receptor inhibitor gefitinib detected using small animal PET imaging

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970353-5

7 January 2021

Molecular imaging of therapeutic response to epidermal growth factor receptor blockade in colorectal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970353-5

7 January 2021

Serial positron emission tomography scans following radiation therapy of patients with head and neck cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970353-5

7 January 2021

A systematic review and meta-analysis of the role of positron emission tomography in the follow up of head and neck squamous cell carcinoma following radiotherapy or chemoradiotherapy.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970353-5

7 January 2021

Evaluation of response to radiotherapy in head and neck cancer by positron emission tomography and [11C]methionine

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970353-5

7 January 2021

Evaluation of chemotherapy response in patients with advanced head and neck cancer using [F-18]fluorodeoxyglucose positron emission tomography

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970353-5

7 January 2021

Management of the neck in a randomized trial comparing concurrent chemotherapy and radiotherapy with radiotherapy alone in resectable stage III and IV squamous cell head and neck cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970353-5

7 January 2021

Ability of positron emission tomography to detect residual neck node disease in patients with head and neck squamous cell carcinoma after definitive chemoradiotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970353-5

7 January 2021

The role of computed tomographic scans in the management of the N-positive neck in head and neck squamous cell carcinoma after chemoradiotherapy.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970353-5

7 January 2021

Clinical utility of 18F-FDG PET/CT in assessing the neck after concurrent chemoradiotherapy for Locoregional advanced head and neck cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970353-5

7 January 2021

Utility of positron emission tomography for the detection of disease in residual neck nodes after (chemo)radiotherapy in head and neck cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970353-5

7 January 2021

The role of FDG PET in management of neck metastasis from head-and-neck cancer after definitive radiation treatment

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970353-5

7 January 2021

10.1016/S1470-2045(09)70353-5

Identifiers

DOI

1 reference

22 August 2017

1 reference

PubMed ID

20226735